theophylline has been researched along with Hepatitis, Alcoholic in 2 studies
Hepatitis, Alcoholic: INFLAMMATION of the LIVER due to ALCOHOL ABUSE. It is characterized by NECROSIS of HEPATOCYTES, infiltration by NEUTROPHILS, and deposit of MALLORY BODIES. Depending on its severity, the inflammatory lesion may be reversible or progress to LIVER CIRRHOSIS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Acute alcoholic hepatitis is associated with significant lymphocyte steroid insensitivity, which improves in recovery and can be ameliorated ex vivo by theophylline." | 9.14 | Theophylline improves steroid sensitivity in acute alcoholic hepatitis. ( Day, CP; Henderson, E; Jones, DE; Kendrick, SF; Palmer, J, 2010) |
| "Acute alcoholic hepatitis is associated with significant lymphocyte steroid insensitivity, which improves in recovery and can be ameliorated ex vivo by theophylline." | 5.14 | Theophylline improves steroid sensitivity in acute alcoholic hepatitis. ( Day, CP; Henderson, E; Jones, DE; Kendrick, SF; Palmer, J, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kendrick, SF | 1 |
| Henderson, E | 1 |
| Palmer, J | 1 |
| Jones, DE | 1 |
| Day, CP | 1 |
| Beyazit, Y | 1 |
| Sayilir, A | 1 |
| Kekilli, M | 1 |
| Kurt, M | 1 |
| Gorgulu, O | 1 |
1 trial available for theophylline and Hepatitis, Alcoholic
| Article | Year |
|---|---|
Theophylline improves steroid sensitivity in acute alcoholic hepatitis.
Topics: Acute Disease; Adrenal Cortex Hormones; Adult; Dexamethasone; Drug Resistance; Drug Therapy, Combina | 2010 |
1 other study available for theophylline and Hepatitis, Alcoholic
| Article | Year |
|---|---|
Phosphoinositide-3-kinase inhibition with theophylline reverses steroid insensitivity in acute alcoholic hepatitis.
Topics: Acute Disease; Enzyme Inhibitors; Hepatitis, Alcoholic; Humans; Phosphoinositide-3 Kinase Inhibitors | 2011 |